# A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain

> **NCT02192190** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 268 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** LY2951742
- **OTHER:** Placebo- oral
- **OTHER:** Placebo - SC
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT02192190
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 268 (ACTUAL)
- **Why stopped:** Interim assessment: Lack of efficacy
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192190, "A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02192190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*